Status:
UNKNOWN
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Lead Sponsor:
University of Vermont
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.
Eligibility Criteria
Inclusion
- Patients with a diagnosis of malignancy
Exclusion
- Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01148407
Start Date
June 1 2010
End Date
August 1 2013
Last Update
April 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont/Fletcher Allen Health Care
Burlington, Vermont, United States, 05401